Registry for Acute Decompensated Heart Failure Patients

This study has been completed.
Sponsor:
Information provided by:
Scios, Inc.
ClinicalTrials.gov Identifier:
NCT00366639
First received: August 18, 2006
Last updated: October 29, 2009
Last verified: October 2009

August 18, 2006
October 29, 2009
October 2001
Not Provided
Course of care in the Emergency Department (ED) and course of care in the inpatient hospital, use of diuretics (increase urine excretion) vasodilators (relax artey and veins) and inotropeic agents (increase the function of the heart) rate of death [ Time Frame: From admission to discharge from the hospital ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00366639 on ClinicalTrials.gov Archive Site
Data from patient demographics ( sex, age, gender, race) [ Time Frame: at patients admission ] [ Designated as safety issue: No ]
Not Provided
Not Provided
Not Provided
 
Registry for Acute Decompensated Heart Failure Patients
ADHERE Core III - Acute Decompensated Heart Failure Registry

The purpose of the ADHERE study is to develop a multi-center, observational, open-label registry of the management strategies of patients treated in the hospital for acute Heart Failure in the United States.

The objective is to compile a clinical database on the strategy for the medical management of patients hospitalized with acute Heart Failure (HF). Through the use of the information collected from acute care hospitals across the United States the following information may be coming out of this study: 1) Assist hospitals in evaluating and improving quality of care for patients with acute HF by tracking quality indicators and providing benchmark data reports; 2) Describe the demographic and clinical characteristics of patients who are hospitalized with acute HF; 3) Characterize the initial emergency department evaluation and subsequent inpatient management of patients hospitalized with acute HF; 4) Identify patient characteristics and medical care practices associated with improved health outcomes in those hospitalized with acute HF; 5) Characterize trends and changes over time in the management of acute HF; 6) Offer surveillance of adherence to practice guidelines as these emerge for the inpatient management of acute HF. Observational Study - No investigational drug administered

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

All consecutive adult patients admitted to an acute care hospital and treated actively for acute HF, where acute HF is defined clinically as a new onset with HF decompensation

  • Heart Failure, Congestive
  • Heart Decompensation
Other: Acute Decompensated Heart Failure
Treatment & outcomes during hospital admission for Acute DHF
001
Intervention: Other: Acute Decompensated Heart Failure

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
24118
February 2006
Not Provided

Inclusion Criteria:

  • Age greater than or equal to 18 years at the time of admission to the hospital
  • Received or is eligible to receive a principal hospital discharge diagnosis of HF
  • Decompensated HF is present as determined clinically by the patient care team

Exclusion Criteria:

  • HF is present as a co-morbid condition, but is not a principal focus of diagnosis or treatment during this hospitalization episode
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00366639
CR005194
Not Provided
Sr. Director, Clinical Team Leader, Scios
Scios, Inc.
Not Provided
Study Director: Scios, Inc. Clinical Trial Scios, Inc.
Scios, Inc.
October 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP